Information from Industry - Sponsored Supplement

Perspectives on Hypercortisolism Diagnosis and Management in Community and Academic Centers

Sponsored by Corcept Therapeutics Incorporated.

 

Lewis Blevins, MD; Richard Auchus, MD, PhD; David Brown, MD, PhD; Amir Hamrahian, MD; and Smita Kargutkar, MD share their insights and real-world perspectives on hypercortisolism diagnosis and management, including:

• The understanding of hypercortisolism has evolved significantly over the past decades to extend beyond classic physical manifestations (e.g., central obesity, facial plethora, buffalo hump, purple striae)

• Early identification of patients with mild autonomous cortisol secretion is important as hypercortisolism can lead to age-inappropriate and treatment-resistant metabolic syndrome

• Patient identification and management approaches for hypercortisolism can differ between academic and community settings due to differences in available resources and multidisciplinary management teams

• Educating primary care providers and community endocrinologists about the consequences of hypercortisolism can be beneficial in bridging the gap between academic and community settings

Lewis Blevins, MD
Meeting Moderator
University of California
San Francisco  
San Francisco, CA

Richard Auchus, MD, PhD
University of Michigan
Ann Arbor, MI

 

 

David Brown, MD, PhD
Private Practice
Rockville, MD

 

 

Amir Hamrahian, MD
Johns Hopkins University
Baltimore, MD

Smita Kargutkar, MD
ACE Endocrinology Associates
Red Bank, NJ

 

Click HERE to read the supplement.

©2022 Corcept Therapeutics Incorporated. All Rights Reserved. DSE-00997 DEC 2022

Recommended Reading

The new obesity breakthrough drugs
MDedge Endocrinology
Have you heard the one about the cow in the doctor’s office?
MDedge Endocrinology
Metabolic syndrome may promote gout in young men
MDedge Endocrinology
DELIVER subanalysis ‘seals deal’ for dapagliflozin in HF
MDedge Endocrinology
Intermittent fasting can lead to type 2 diabetes remission
MDedge Endocrinology